Your browser doesn't support javascript.
loading
Inotuzumabozogamicin is an effective treatment for CD22-positive acute undifferentiated leukemia: A case report.
Akazawa, Ryo; Kato, Itaru; Kubota, Hirohito; Isobe, Kiyotaka; Masuno, Hiroaki; Mikami, Masamitsu; Shiota, Mitsutaka; Kouzuki, Kagehiro; Kawabata, Naoko; Tanaka, Kuniaki; Saida, Satoshi; Umeda, Katsutsugu; Hiramatsu, Hidefumi; Adachi, Souichi; Takita, Junko.
Affiliation
  • Akazawa R; Department of Pediatrics, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Kato I; Department of Pediatrics, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Kubota H; Department of Pediatrics, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Isobe K; Department of Pediatrics, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Masuno H; Department of Pediatrics, Kitano Hospital, The Tazuke Kofukai, Medical Research Institute, Osaka, Japan.
  • Mikami M; Department of Pediatrics, Kitano Hospital, The Tazuke Kofukai, Medical Research Institute, Osaka, Japan.
  • Shiota M; Department of Pediatrics, Kitano Hospital, The Tazuke Kofukai, Medical Research Institute, Osaka, Japan.
  • Kouzuki K; Department of Pediatrics, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Kawabata N; Department of Pediatrics, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Tanaka K; Department of Pediatrics, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Saida S; Department of Pediatrics, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Umeda K; Department of Pediatrics, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Hiramatsu H; Department of Pediatrics, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Adachi S; Department of Human Health Sciences, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Takita J; Department of Pediatrics, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Pediatr Blood Cancer ; 68(5): e28976, 2021 05.
Article in En | MEDLINE | ID: mdl-33619873
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia / Sialic Acid Binding Ig-like Lectin 2 / Antineoplastic Agents, Immunological / Inotuzumab Ozogamicin Limits: Adolescent / Female / Humans Language: En Journal: Pediatr Blood Cancer Journal subject: HEMATOLOGIA / NEOPLASIAS / PEDIATRIA Year: 2021 Document type: Article Affiliation country: Japan Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia / Sialic Acid Binding Ig-like Lectin 2 / Antineoplastic Agents, Immunological / Inotuzumab Ozogamicin Limits: Adolescent / Female / Humans Language: En Journal: Pediatr Blood Cancer Journal subject: HEMATOLOGIA / NEOPLASIAS / PEDIATRIA Year: 2021 Document type: Article Affiliation country: Japan Country of publication: United States